West Pharmaceutical Services (WST) Non Operating Income (2016 - 2025)
Historic Non Operating Income for West Pharmaceutical Services (WST) over the last 15 years, with Q4 2025 value amounting to -$18.5 million.
- West Pharmaceutical Services' Non Operating Income fell 8137.25% to -$18.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$51.2 million, marking a year-over-year decrease of 14380.95%. This contributed to the annual value of -$51.2 million for FY2025, which is 14380.95% down from last year.
- According to the latest figures from Q4 2025, West Pharmaceutical Services' Non Operating Income is -$18.5 million, which was down 8137.25% from -$6.9 million recorded in Q3 2025.
- West Pharmaceutical Services' 5-year Non Operating Income high stood at $9.7 million for Q3 2023, and its period low was -$50.0 million during Q3 2022.
- In the last 5 years, West Pharmaceutical Services' Non Operating Income had a median value of -$4.2 million in 2023 and averaged -$7.3 million.
- In the last 5 years, West Pharmaceutical Services' Non Operating Income surged by 19000.0% in 2021 and then tumbled by 267777.78% in 2022.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Non Operating Income stood at -$11.5 million in 2021, then soared by 115.65% to $1.8 million in 2022, then plummeted by 594.44% to -$8.9 million in 2023, then decreased by 14.61% to -$10.2 million in 2024, then tumbled by 81.37% to -$18.5 million in 2025.
- Its last three reported values are -$18.5 million in Q4 2025, -$6.9 million for Q3 2025, and -$5.2 million during Q2 2025.